entity

TAC

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about TAC: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
21Hypotheses
0Analyses
1Outgoing
0Incoming
13Experiments
0Debates

No AI portrait yet

Wiki Pages (16)

Knowledge base pages for this entity

PROTAC Therapy for Parkinson's Disease

therapeutic · 2799 words

BBB-Transcytosis Shuttle for Episodic CNS PROTAC Delivery

idea · 2404 words

Tau PROTAC and Degraders - Targeted Protein Degradation for Tau

mechanism · 2399 words

Tau-PROTAC Heterobifunctional Degrader for Tauopathy

idea · 2373 words

Targeted Protein Degradation (PROTACs)

therapeutic · 2338 words

Outgoing (1)

TargetRelationTypeStr
TERTactivatesgene0.70

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (21)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Closed-loop tACS targeting EC-II parvalbumin interneurons to 0.869 alzheimers Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II PV interneurons to suppress 0.811 alzheimers Circuit-level neural dynamics in neurode
Selective APOE4 Degradation via Proteolysis Targeting Chimer 0.795 neurodegeneration APOE4 structural biology and therapeutic
Closed-loop tACS targeting entorhinal cortex layer II SST in 0.784 alzheimers Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II SST interneurons to block t 0.752 alzheimers Circuit-level neural dynamics in neurode
GBA1-Deficiency Disrupts Mitochondrial- Lysosomal Contact Si 0.747 neurodegeneration -
Granzyme B Inhibition with Serpina3n to Preserve Axonal Inte 0.698 neuroimmunology Do CXCL10-recruited CD8+ T cells provide
Mitochondrial-Lysosomal Contact Site Engineering 0.668 neurodegeneration Autophagy-lysosome pathway convergence a
Closed-loop tACS targeting EC-II PV interneurons to enhance 0.596 alzheimers Circuit-level neural dynamics in neurode
Closed-loop tACS targeting EC-II somatostatin interneurons t 0.564 alzheimers Circuit-level neural dynamics in neurode
ER-mitochondria contact-site dysfunction in neurodegeneratio 0.530 neurodegeneration Test
CSF p-tau217 Normalization Requires Intact Synaptic Function 0.515 neurodegeneration -
Neurogranulin Predicts p-tau217 Reliability by Identifying P 0.498 neurodegeneration -
Cerebral VSMC foam cells induce pericyte detachment via PDGF 0.473 neurodegeneration How does P2RY12-mediated VSMC dysfunctio
Mitochondrial Contact Site Stabilization 0.455 neurodegeneration Which specific metabolic pathways in APO
PU.1 Degradation via PROTAC for Inflammatory Microglial Pola 0.408 neurodegeneration Microglial subtypes in neurodegeneration
ATAC-seq accessibility separates causal from compensatory st 0.342 neurodegeneration Are DNA methylation changes in neurodege
ATAC-seq accessibility separates causal from compensatory st 0.327 neurodegeneration Are age-related DNA methylation changes
Prostacyclin (PGI2) Signaling via IP Receptor 0.320 neurodegeneration Which specific factors in conditioned me
Mitochondrial-Lysosomal Contact Site Modulators 0.000 - GBA-Synuclein Loop Therapeutics for PD
p21-Targeted Proteolysis-Targeting Chimeras (PROTACs) 0.000 - Senolytic therapy for age-related neurod

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (13)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
GWAS of plasma NfL in East Asian cohort exploratory Alzheimer's disease 0.950 0.00 human patients - East Asian co proposed N/A
GWAS of plasma pTau217 in East Asian cohort exploratory Alzheimer's disease 0.950 0.00 human patients - East Asian co proposed N/A
Dairy intake and dementia risk in Malmö Diet and Cancer cohort clinical Alzheimer's disease 0.950 0.00 Swedish community-based adults proposed N/A
GWAS of plasma pTau181 in East Asian cohort exploratory Alzheimer's disease 0.950 0.00 human patients - East Asian co proposed N/A
GWAS of plasma GFAP in East Asian cohort exploratory Alzheimer's disease 0.950 0.00 human patients - East Asian co proposed N/A
KEEPS Continuation: Long-term effects of menopausal hormone therapy on clinical Alzheimer's disease 0.950 0.00 recently menopausal women with proposed N/A
GWAS of composite biomarker score exploratory Alzheimer's disease 0.900 0.00 human patients - East Asian co proposed N/A
RBG treatment in ApoE-/- atherosclerosis mouse model validation atherosclerosis 0.900 0.00 ApoE-/- mice proposed N/A
s:** - Biochemical binding assays measuring PROTAC selectivity for APO falsification Neurodegeneration 0.400 0.50 cell_line proposed $100,000
Why Does Amyloid Removal Only Slow Decline 27%? — Mechanistic investig clinical Alzheimer's Disease 0.400 0.50 human proposed $7,100,000
Validate Mitochondria-Lysosome Contact Site Dysfunction in PD validation Parkinson's Disease 0.400 0.50 human proposed $2,730,000
MLCS Quantification in Parkinson's Disease validation Parkinson's Disease 0.400 0.50 human proposed $2,730,000
TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism and Therapeu validation Neurodegeneration 0.400 0.50 human proposed $2,730,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Lactate accumulation drives hepatocellular carcinoma metastasis through facilita [PMID:40120799] Jiang C, He X, Chen X, Huang J, Liu Y, Z Cancer Lett 2025 1
Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegenerat [PMID:37995685] Litvinchuk A, Suh JH, Guo JL, Lin K, Dav Neuron 2024 1
The cell biology of APOE in the brain. [PMID:37805344] Windham IA, Cohen S Trends Cell Biol 2024 1
The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegene [PMID:37957317] Maxine R Nelson, Peng Liu, Ayushi Agrawa Nature neuroscience 2023 1
TSPAN1 promotes autophagy flux and mediates cooperation between WNT-CTNNB1 signa [PMID:32972302] Zhou C, Liang Y, Zhou L, Yan Y, Liu N, Z Autophagy 2021 1
Role of the endolysosomal pathway and exosome release in tau propagation. [PMID:33582164] Yan M, Zheng T Neurochem Int 2021 1
APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therape [PMID:33340485] Serrano-Pozo A, Das S, Hyman BT Lancet Neurol 2021 1
Lysosome-targeting chimaeras for degradation of extracellular proteins. [PMID:32728216] Banik SM, Pedram K, Wisnovsky S, Ahn G, Nature 2020 1
Rab7a and Mitophagosome Formation. [PMID:30857122] Tan EHN, Tang BL Cells 2019 1
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. [PMID:31564456] Long JM, Holtzman DM Cell 2019 1
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. [PMID:31367008] Yamazaki Y, Zhao N, Caulfield TR, Liu CC Nat Rev Neurol 2019 1
Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associate [PMID:41905188] Cetindag AC, Schipke CG, Esselmann H, Kr The journal of prevention of A 2026 0
Perioperative polygenic and APOE-based genetic risk assessment for neurocognitiv [PMID:40562635] Thedim M, Hu J, Maher M, Wiener-Kronish Br J Anaesth 2026 0
Increased genetic protection against Alzheimer's disease in centenarians. [PMID:40615639] Bae H, Song Z, Ali A, Sasaki T, Tesi N e Geroscience 2026 0
Integrative machine learning approach to risk prediction for dementia and Alzhei [PMID:40864401] Stern A, Linial M Geroscience 2026 0
Adipose Tissue Macrophage-Derived Proplatelet Basic Protein Exacerbates Psoriasi [PMID:40886963] Zhu L, Du L, Wu J, Ding D, Wang J et al. J Invest Dermatol 2026 0
Restoration of p53 mRNA combined with BRD4 silencing by brain targeted nanocapsu [PMID:41101204] Sang Y, Cao Y, Li S, Quan Y, Wang S et a Biomaterials 2026 0
Targeting KAT8 alleviates vascular senescence by modulating the INHBA/TGF-β path [PMID:41445196] Lin Z, Xiong J, Zhang F, Zhang H, Zhu M Mol Ther 2026 0
Menopause, cognition, and Alzheimer's disease risk. [PMID:41531227] Samudra N, Vemuri M, Weitlauf J Curr Opin Obstet Gynecol 2026 0
YY1 nitration participates in DbCM cardiomyocyte lipotoxicity by inhibiting ANXA [PMID:41702019] Chai J, Han L, Mo D, Bai Y, Yang Y et al Redox Biol 2026 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning TAC in their description or question text

Granzyme B Inhibition with Serpina3n to Preserve Axonal Integrity Against Cytoto

Score: 0.698 · neuroimmunology · 2026-04-15

## Mechanistic Overview Granzyme B Inhibition with Serpina3n to Preserve Axonal Integrity Against Cytotoxic Attack start

Mitochondrial-Lysosomal Contact Site Engineering

Score: 0.668 · neurodegeneration · 2026-04-02

## Mechanistic Overview Mitochondrial-Lysosomal Contact Site Engineering starts from the claim that modulating RAB7A wit

Closed-loop tACS targeting EC-II PV interneurons to enhance perisomatic inhibiti

Score: 0.596 · alzheimers · 2026-04-07

## Mechanistic Overview Closed-loop tACS targeting EC-II PV interneurons to enhance perisomatic inhibition and block tau

Closed-loop tACS targeting EC-II somatostatin interneurons to restore dendritic

Score: 0.564 · alzheimers · 2026-04-20

## Mechanistic Overview Closed-loop tACS targeting EC-II somatostatin interneurons to restore dendritic integration and

ER-mitochondria contact-site dysfunction in neurodegeneration

Score: 0.530 · neurodegeneration · 2026-04-30

Altered mitochondria-associated membranes may disrupt calcium transfer, lipid synthesis, ROS handling, and apoptotic thr

Cerebral VSMC foam cells induce pericyte detachment via PDGF-BB/VEGF imbalance,

Score: 0.473 · neurodegeneration · 2026-04-21

## Mechanistic Overview Cerebral VSMC foam cells induce pericyte detachment via PDGF-BB/VEGF imbalance, impairing neurov

Mitochondrial Contact Site Stabilization

Score: 0.455 · neurodegeneration · 2026-04-27

Target VDAC1-GRP75-IP3R1 complex to restore mitochondrial-ER communication and metabolic flexibility by addressing funda

PU.1 Degradation via PROTAC for Inflammatory Microglial Polarization

Score: 0.408 · neurodegeneration · 2026-04-25

NOT RECOMMENDED. Critical safety contraindications: PU.1 knockout is embryonic lethal in mice; PU.1 haploinsufficiency i

ATAC-seq accessibility separates causal from compensatory states in: Are DNA met

Score: 0.342 · neurodegeneration · 2026-04-26

A longitudinal biomarker panel centered on ATAC-seq accessibility can distinguish harmful mechanisms from protective ada

ATAC-seq accessibility separates causal from compensatory states in: Are age-rel

Score: 0.327 · neurodegeneration · 2026-04-26

A longitudinal biomarker panel centered on ATAC-seq accessibility can distinguish harmful mechanisms from protective ada

Prostacyclin (PGI2) Signaling via IP Receptor

Score: 0.320 · neurodegeneration · 2026-04-25

Healthy astrocytes produce prostaglandin I2 (prostacyclin), which signals via IP receptor on motor neurons, elevating cA

Mitochondrial-Lysosomal Contact Site Modulators

Score: 0.000 · unknown disease · 2026-04-28

Targeting disrupted VDAC1-LAMP1 interactions to restore calcium homeostasis and ATP supply to lysosomes Debate provenan